BioCryst Pharmaceuticals, Inc.
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
Last updated:
Abstract:
Disclosed are compounds of formulae I and II, and pharmaceutically acceptable salts and prodrugs thereof, which are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising such a compound, and methods of using the compounds and compositions in the treatment or prevention of a disease or condition characterized by aberrant complement system activity. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
15 Jul 2019
Issue date:
1 Jun 2021